Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 9, Pages 3354
Publisher
MDPI AG
Online
2020-05-11
DOI
10.3390/ijms21093354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pol II phosphorylation regulates a switch between transcriptional and splicing condensates
- (2019) Yang Eric Guo et al. NATURE
- Evaluating phase separation in live cells: diagnosis, caveats, and functional consequences
- (2019) David T. McSwiggen et al. GENES & DEVELOPMENT
- c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach
- (2018) Loana Musso et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- CDK9 inhibitors in acute myeloid leukemia
- (2018) Silvia Boffo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
- (2018) Hetal Patel et al. MOLECULAR CANCER THERAPEUTICS
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
- (2018) Shao-Ru Chen et al. Frontiers in Pharmacology
- Transcription of Nearly All Yeast RNA Polymerase II-Transcribed Genes Is Dependent on Transcription Factor TFIID
- (2017) Linda Warfield et al. MOLECULAR CELL
- Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
- (2017) Calla M Olson et al. Nature Chemical Biology
- The Mediator Complex: At the Nexus of RNA Polymerase II Transcription
- (2017) Célia Jeronimo et al. TRENDS IN CELL BIOLOGY
- The emerging roles of CDK12 in tumorigenesis
- (2017) Hana Paculová et al. Cell Division
- THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
- (2017) Florencia Cayrol et al. Nature Communications
- Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
- (2017) Maria Rusan et al. Cancer Discovery
- SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
- (2017) Tomasz Rzymski et al. Oncotarget
- Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
- (2017) S A Greenall et al. Oncogenesis
- Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
- (2017) Ioana I. Nitulescu et al. EBioMedicine
- A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
- (2017) Shu-Fu Lin et al. PLoS One
- Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
- (2016) Qing-Li He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Drugging Undruggable Molecular Cancer Targets
- (2016) John S. Lazo et al. Annual Review of Pharmacology and Toxicology
- Structure of a Complete Mediator-RNA Polymerase II Pre-Initiation Complex
- (2016) Philip J. Robinson et al. CELL
- Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
- (2016) Yan-Yi Jiang et al. GUT
- Mediator Undergoes a Compositional Change during Transcriptional Activation
- (2016) Natalia Petrenko et al. MOLECULAR CELL
- Tail and Kinase Modules Differently Regulate Core Mediator Recruitment and Function In Vivo
- (2016) Célia Jeronimo et al. MOLECULAR CELL
- Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
- (2016) Tinghu Zhang et al. Nature Chemical Biology
- Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
- (2016) Victoria E Clark et al. NATURE GENETICS
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
- (2016) Paul A Clarke et al. eLife
- α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15
- (2016) Kohei Kume et al. Scientific Reports
- CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
- (2015) Yubao Wang et al. CELL
- Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia
- (2015) Mark C. Lanasa et al. LEUKEMIA RESEARCH
- Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
- (2015) Kaiwei Liang et al. MOLECULAR AND CELLULAR BIOLOGY
- Mediator kinase inhibition further activates super-enhancer-associated genes in AML
- (2015) Henry E. Pelish et al. NATURE
- TP53 loss creates therapeutic vulnerability in colorectal cancer
- (2015) Yunhua Liu et al. NATURE
- Targeting transcription is no longer a quixotic quest
- (2015) Anna K Mapp et al. Nature Chemical Biology
- A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
- (2015) Trevor Dale et al. Nature Chemical Biology
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- The selection and function of cell type-specific enhancers
- (2015) Sven Heinz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural basis of transcription initiation by RNA polymerase II
- (2015) Sarah Sainsbury et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Mediator complex: a central integrator of transcription
- (2015) Benjamin L. Allen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Getting up to speed with transcription elongation by RNA polymerase II
- (2015) Iris Jonkers et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Double-stranded DNA translocase activity of transcription factor TFIIH and the mechanism of RNA polymerase II open complex formation
- (2015) James Fishburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
- (2015) Huasong Lu et al. eLife
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
- (2014) Camilla L. Christensen et al. CANCER CELL
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- RNA polymerase II pausing during development
- (2014) B. Gaertner et al. DEVELOPMENT
- The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo
- (2014) GUI’E XIE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl-2
- (2014) AJDA COKER-GURKAN et al. Molecular Medicine Reports
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
- (2014) Nadine Löschmann et al. Translational Oncology
- Transcriptional Regulation and Its Misregulation in Disease
- (2013) Tong Ihn Lee et al. CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Mechanisms of Mediator complex action in transcriptional activation
- (2013) Suraiya A. Ansari et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities
- (2013) Hao Shao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression
- (2013) Miriam Merzel Schachter et al. MOLECULAR CELL
- A conserved Mediator–CDK8 kinase module association regulates Mediator–RNA polymerase II interaction
- (2013) Kuang-Lei Tsai et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis of transcription elongation
- (2012) Fuensanta W. Martinez-Rucobo et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The RNA polymerase II CTD coordinates transcription and RNA processing
- (2012) J.-P. Hsin et al. GENES & DEVELOPMENT
- Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity
- (2012) Alison J. Hole et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
- (2012) Stéphane Larochelle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cyclin K goes with Cdk12 and Cdk13
- (2012) Jiri Kohoutek et al. Cell Division
- Transcriptional modulation of apoptosis regulators by roscovitine and related compounds
- (2011) Xènia Garrofé-Ochoa et al. APOPTOSIS
- TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
- (2011) K C Goh et al. LEUKEMIA
- The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine
- (2011) E Walsby et al. LEUKEMIA
- Structural Insights to How Mammalian Capping Enzyme Reads the CTD Code
- (2011) Agnidipta Ghosh et al. MOLECULAR CELL
- XPB, a subunit of TFIIH, is a target of the natural product triptolide
- (2011) Denis V Titov et al. Nature Chemical Biology
- Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB
- (2010) Sonja Baumli et al. CHEMISTRY & BIOLOGY
- Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies
- (2010) Christophe Le Tourneau et al. EUROPEAN JOURNAL OF CANCER
- Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
- (2010) Wei-Gang Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Interactions between DSIF (DRB sensitivity inducing factor), NELF (negative elongation factor), and the Drosophila RNA polymerase II transcription elongation complex
- (2010) A. Missra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases
- (2010) Kamil Paruch et al. ACS Medicinal Chemistry Letters
- Cortistatin A is a High-Affinity Ligand of Protein Kinases ROCK, CDK8, and CDK11
- (2009) Victor J. Cee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
- (2009) Andrew Conroy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
- (2009) S. Ali et al. CANCER RESEARCH
- Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease
- (2009) Thomas S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
- (2009) M. S. Squires et al. MOLECULAR CANCER THERAPEUTICS
- Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia
- (2008) M. A. Phelps et al. BLOOD
- Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicinin vivoin a breast cancer xenograft model
- (2008) Maria Virginia C.L. Appleyard et al. INTERNATIONAL JOURNAL OF CANCER
- The RNA Polymerase II Trigger Loop Functions in Substrate Selection and Is Directly Targeted by α-Amanitin
- (2008) Craig D. Kaplan et al. MOLECULAR CELL
- A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity
- (2008) Alessia Montagnoli et al. Nature Chemical Biology
- Structural basis of transcription inhibition by α-amanitin and implications for RNA polymerase II translocation
- (2008) Florian Brueckner et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
- (2008) K Bettayeb et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now